Genetic lesions in a preleukemic aplasia phase in a child with acute lymphoblastic leukemia

• Published in: Genes chromosomes & cancer Vol. 47; no. 4; pp. 333 - 340
• Main Authors: Horsley, Sharon W., Colman, Susan, McKinley, Mark, Bateman, Caroline M., Jenney, Meriel, Chaplin, Tracy, Young, Bryan D., Greaves, Mel, Kearney, Lyndal
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.04.2008
• Subjects: Anemia, Aplastic - complications; Anemia, Aplastic - genetics; Anemia, Aplastic - pathology; Bone Marrow - pathology; Child, Preschool; Core Binding Factor Alpha 2 Subunit - genetics; Genotype; Humans; In Situ Hybridization, Fluorescence; Male; Microarray Analysis; Oligonucleotide Array Sequence Analysis; Oncogene Proteins, Fusion - genetics; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics; Preleukemia - genetics; Preleukemia - pathology; Retrospective Studies
• ISSN: 1045-2257; 1098-2264
• DOI: 10.1002/gcc.20537

In a small fraction (∼2%) of cases of childhood acute lymphoblastic leukemia (ALL) clinical presentation of leukemia is preceded, some 2–9 months earlier, by a transient, remitting phase of nonclassical aplastic anemia, usually in connection with infection. The potential “preleukemic” nature of this prodromal phase has not been fully explored. We have retrospectively analyzed the blood and bone marrow of a child who presented with aplastic anemia 9 months before the development of ETV6‐RUNX1 fusion gene positive ALL. High resolution SNP genotyping arrays identified 11 regions of loss of heterozygosity, with and without concurrent copy number changes, at the presentation of ALL. In all cases of copy number change, the deletion or gain identified by single nucleotide polymorphism (SNP) analysis was confirmed in the ALL blasts by FISH. Retrospective analysis of aplastic phase bone marrow showed that the ETV6‐RUNX1 fusion was present along with all of the additional genetic changes assessed, albeit subclonal to ETV6‐RUNX1. These data identify for the first time the leukemic genotype of an aplasia preceding clinical ALL and indicate that multiple secondary genetic abnormalities can contribute to a dominant subclone several months before a diagnosis of ALL. These data have implications for the biology of ALL and for management of similar patients. © 2008 Wiley‐Liss, Inc.